Works by Montefusco, Vittorio


Results: 33
    1
    2

    Unrelated donor haematopoietic cell transplantation after non-myeloablative conditioning for patients with high-risk multiple myeloma.

    Published in:
    European Journal of Haematology, 2007, v. 78, n. 4, p. 330, doi. 10.1111/j.1600-0609.2007.00816.x
    By:
    • Bruno, Benedetto;
    • Sorasio, Roberto;
    • Patriarca, Francesca;
    • Montefusco, Vittorio;
    • Guidi, Stefano;
    • Busca, Alessandro;
    • Scimé, Rosanna;
    • Console, Giuseppe;
    • Milone, Giuseppe;
    • Marotta, Giuseppe;
    • Dominietto, Alida;
    • Giaccone, Luisa;
    • Rotta, Marcello;
    • Falda, Michele;
    • Bacigalupo, Andrea;
    • Bosi, Alberto;
    • Corradini, Paolo;
    • Fanin, Renato;
    • Pollichieni, Simona;
    • Boccadoro, Mario
    Publication type:
    Article
    3

    Bortezomib- and thalidomide-induced peripheral neuropathy in multiple myeloma: clinical and molecular analyses of a phase 3 study.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 12, p. 1085, doi. 10.1002/ajh.23835
    By:
    • Tacchetti, Paola;
    • Terragna, Carolina;
    • Galli, Monica;
    • Zamagni, Elena;
    • Petrucci, Maria Teresa;
    • Pezzi, Annalisa;
    • Montefusco, Vittorio;
    • Martello, Marina;
    • Tosi, Patrizia;
    • Baldini, Luca;
    • Peccatori, Jacopo;
    • Ruggieri, Miriana;
    • Pantani, Lucia;
    • Lazzaro, Antonio;
    • Elice, Francesca;
    • Rocchi, Serena;
    • Gozzetti, Alessandro;
    • Cavaletti, Guido;
    • Palumbo, Antonio;
    • Cavo, Michele
    Publication type:
    Article
    4
    5

    Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents.

    Published in:
    2020
    By:
    • Mina, Roberto;
    • Joseph, Nisha S.;
    • Gay, Francesca;
    • Kastritis, Efstathios;
    • Petrucci, Maria Teresa;
    • Kaufman, Jonathan L.;
    • Montefusco, Vittorio;
    • Gavriatopoulou, Maria;
    • Patriarca, Francesca;
    • Omedé, Paola;
    • Boise, Lawrence H.;
    • Roussou, Maria;
    • Giuliani, Nicola;
    • Oliva, Stefania;
    • Offidani, Massimo;
    • Belotti, Angelo;
    • Jaye, David L.;
    • De Paoli, Lorenzo;
    • Terpos, Evangelos;
    • Lonial, Sagar
    Publication type:
    Letter
    6

    Lenalidomide can induce long-term responses in patients with multiple myeloma relapsing after multiple chemotherapy lines, in particular after allogeneic transplant.

    Published in:
    Leukemia & Lymphoma, 2011, v. 52, n. 7, p. 1262, doi. 10.3109/10428194.2011.564695
    By:
    • Spina, Francesco;
    • Montefusco, Vittorio;
    • Crippa, Claudia;
    • Citro, Annalisa;
    • Sammassimo, Simona;
    • Olivero, Barbara;
    • Gentili, Silvia;
    • Galli, Monica;
    • Guglielmelli, Tommasina;
    • Rossi, Davide;
    • Pia falcone, Antonietta;
    • Grasso, Mariella;
    • Patriarca, Francesca;
    • De muro, Marianna;
    • Corradini, Paolo
    Publication type:
    Article
    7
    8

    P895: DARATUMUMAB PLUS POMALIDOMIDE AND DEXAMETHASONE (DPD) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND 17P DELETION: UPDATED ANALYSIS OF THE DEDALO PHASE II TRIAL.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000970484.72978.5d
    By:
    • Montefusco, Vittorio;
    • Maria Cafro, Anna;
    • Margiotta‐Casaluci, Gloria;
    • Patriarca, Francesca;
    • Mina, Roberto;
    • D’agostino5, Mattia;
    • Palma, Anna Benedetta Dalla;
    • Rizzi, Rita;
    • Genua, Angelo;
    • Fazio, Francesca;
    • Paris, Laura;
    • Belotti, Angelo;
    • Rizzello, Ilaria;
    • Conticello, Concetta;
    • Carlo‐Stella, Carmelo;
    • Boccadoro, Mario
    Publication type:
    Article
    9
    10
    11
    12

    Autoimmune diseases during treatment with immunomodulatory drugs in multiple myeloma: selective occurrence after lenalidomide.

    Published in:
    Leukemia & Lymphoma, 2014, v. 55, n. 9, p. 2032, doi. 10.3109/10428194.2014.914203
    By:
    • Montefusco, Vittorio;
    • Galli, Monica;
    • Spina, Francesco;
    • Stefanoni, Paola;
    • Mussetti, Alberto;
    • Perrone, Giulia;
    • De Philippis, Chiara;
    • Dalto, Serena;
    • Maura, Francesco;
    • Bonini, Chiara;
    • Rezzonico, Francesca;
    • Pennisi, Martina;
    • Roncari, Luisa;
    • Soldarini, Martina;
    • Dodero, Anna;
    • Farina, Lucia;
    • Cocito, Federica;
    • Caprioli, Chiara;
    • Corradini, Paolo
    Publication type:
    Article
    13
    14
    15

    New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment?

    Published in:
    Expert Opinion on Biological Therapy, 2017, v. 17, n. 7, p. 821, doi. 10.1080/14712598.2017.1324567
    By:
    • Patriarca, Francesca;
    • Giaccone, Luisa;
    • Onida, Francesco;
    • Castagna, Luca;
    • Sarina, Barbara;
    • Montefusco, Vittorio;
    • Mussetti, Alberto;
    • Mordini, Nicola;
    • Maino, Elena;
    • Greco, Raffaella;
    • Peccatori, Jacopo;
    • Festuccia, Moreno;
    • Zaja, Francesco;
    • Volpetti, Stefano;
    • Risitano, Antonio;
    • Bassan, Renato;
    • Corradini, Paolo;
    • Ciceri, Fabio;
    • Fanin, Renato;
    • Baccarani, Michele
    Publication type:
    Article
    16
    17

    Identification of four new translocations involving FGFR1 in myeloid disorders.

    Published in:
    Genes, Chromosomes & Cancer, 2001, v. 32, n. 2, p. 155, doi. 10.1002/gcc.1177
    By:
    • Sohal, Jastinder;
    • Chase, Andrew;
    • Mould, Sarah;
    • Corcoran, Martin;
    • Oscier, David;
    • Iqbal, Sameena;
    • Parker, Sally;
    • Welborn, Jeanna;
    • Harris, Richard I.;
    • Martinelli, Giovanni;
    • Montefusco, Vittorio;
    • Sinclair, Paul;
    • Wilkins, Bridget S.;
    • van den Berg, Henk;
    • Vanstraelen, Danny;
    • Goldman, John M.;
    • Cross, Nicholas C.P.
    Publication type:
    Article
    18

    Experts’ consensus on the definition and management of high risk multiple myeloma.

    Published in:
    Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2022.1096852
    By:
    • Marcon, Chiara;
    • Simeon, Valentina;
    • Deias, Paola;
    • Facchin, Gabriele;
    • Corso, Alessandro;
    • Derudas, Daniele;
    • Montefusco, Vittorio;
    • Offidani, Massimo;
    • Teresa Petrucci, Maria;
    • Zambello, Renato;
    • Stocchi, Raffaella;
    • Fanin, Renato;
    • Patriarca, Francesca
    Publication type:
    Article
    19

    Carfilzomib, bendamustine, and dexamethasone in patients with advanced multiple myeloma: The EMN09 phase 1/2 study of the European Myeloma Network.

    Published in:
    Cancer (0008543X), 2021, v. 127, n. 18, p. 3413, doi. 10.1002/cncr.33647
    By:
    • Gay, Francesca;
    • Günther, Andreas;
    • Offidani, Massimo;
    • Engelhardt, Monika;
    • Salvini, Marco;
    • Montefusco, Vittorio;
    • Patriarca, Francesca;
    • Aquino, Sara;
    • Pönisch, Wolfram;
    • Spada, Stefano;
    • Schub, Natalie;
    • Gentili, Silvia;
    • Wäsch, Ralph;
    • Corradini, Paolo;
    • Straka, Christian;
    • Palumbo, Antonio;
    • Einsele, Hermann;
    • Boccadoro, Mario;
    • Sonneveld, Pieter;
    • Gramatzki, Martin
    Publication type:
    Article
    20
    21

    Bortezomib, cyclophosphamide, dexamethasone versus lenalidomide, cyclophosphamide, dexamethasone in multiple myeloma patients at first relapse.

    Published in:
    British Journal of Haematology, 2020, v. 188, n. 6, p. 907, doi. 10.1111/bjh.16287
    By:
    • Montefusco, Vittorio;
    • Corso, Alessandro;
    • Galli, Monica;
    • Ardoino, Ilaria;
    • Pezzatti, Sara;
    • Carniti, Cristina;
    • Patriarca, Francesca;
    • Gherlinzoni, Filippo;
    • Zambello, Renato;
    • Sammassimo, Simona;
    • Marcatti, Magda;
    • Nozza, Andrea;
    • Crippa, Claudia;
    • Cafro, Anna Maria;
    • Baldini, Luca;
    • Corradini, Paolo
    Publication type:
    Article
    22
    23

    Timing the initiation of multiple myeloma.

    Published in:
    Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-15740-9
    By:
    • Rustad, Even H.;
    • Yellapantula, Venkata;
    • Leongamornlert, Daniel;
    • Bolli, Niccolò;
    • Ledergor, Guy;
    • Nadeu, Ferran;
    • Angelopoulos, Nicos;
    • Dawson, Kevin J.;
    • Mitchell, Thomas J.;
    • Osborne, Robert J.;
    • Ziccheddu, Bachisio;
    • Carniti, Cristiana;
    • Montefusco, Vittorio;
    • Corradini, Paolo;
    • Anderson, Kenneth C.;
    • Moreau, Philippe;
    • Papaemmanuil, Elli;
    • Alexandrov, Ludmil B.;
    • Puente, Xose S.;
    • Campo, Elias
    Publication type:
    Article
    24
    25
    26

    Place in therapy of innovative drugs in multiple myeloma in 2021 and 2023 according to an expert panel Delphi consensus.

    Published in:
    Global & Regional Health Technology Assessment, 2021, v. 8, n. 1, p. 80, doi. 10.33393/grhta.2021.2245
    By:
    • Mario, Boccadoro;
    • Patrizia, Berto;
    • Sara, Bringhen;
    • Elena, Zamagni;
    • Patrizia, Tosi;
    • Nicola, Cascavilla;
    • Nicola, Giuliani;
    • Donato, Mannina;
    • Renato, Zambello;
    • Francesca, Patriarca;
    • Vittorio, Montefusco;
    • Mariella, Grasso;
    • Francesco, Di Raimondo;
    • Massimo, Offidani;
    • Maria Teresa, Petrucci;
    • Pellegrino, Musto
    Publication type:
    Article
    27

    Carfilzomib, bendamustine, dexamethasone in patients with advanced multiple myeloma: The EMN09 Phase I/II study of the European Myeloma Network.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e256, doi. 10.1016/j.clml.2019.09.424
    By:
    • Gramatzki, Martin;
    • Offidani, Massimo;
    • Günther, Andreas;
    • Engelhardt, Monika;
    • Salvini, Marco;
    • Montefusco, Vittorio;
    • Patriarca, Francesca;
    • Angelucci, Emanuele;
    • Poenisch, Wolfram;
    • Spada, Stefano;
    • Schub, Natalie;
    • Gentili, Silvia;
    • Wäsch, Ralph;
    • Corradini, Paolo;
    • Einsele, Hermann;
    • Boccadoro, Mario;
    • Sonneveld, Pieter;
    • Gay, Francesca
    Publication type:
    Article
    28

    Analysis of the genomic and transcriptomic landscape of chemoresistant multiple myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e58, doi. 10.1016/j.clml.2019.09.091
    By:
    • Ziccheddu, Bachisio;
    • Biancon, Giulia;
    • Dugo, Matteo;
    • Devecchi, Andrea;
    • De Philippis, Chiara;
    • Bagnoli, Filippo;
    • Maura, Francesco;
    • De Cecco, Loris;
    • Gimondi, Silvia;
    • Vendramin, Antonio;
    • Terragna, Carolina;
    • Martello, Marina;
    • Bagratuni, Tina;
    • Kastritis, Efstathios;
    • Dimopoulos, Meletios A.;
    • Cavo, Michele;
    • Sensi, Maria Luisa;
    • Carniti, Cristiana;
    • Montefusco, Vittorio;
    • Corradini, Paolo
    Publication type:
    Article
    29

    Timing the initiation of multiple myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e6, doi. 10.1016/j.clml.2019.09.008
    By:
    • Maura, Francesco;
    • Rustad, Even;
    • Yellapantula, Venkata;
    • Bolli, Niccolo;
    • Leongamornlert, Daniel;
    • Nadeu, Ferran;
    • Angelopoulos, Nicos;
    • Dawson, Kevin;
    • Mitchell, Thomas;
    • Osborne, Rob;
    • Ziccheddu, Bachisio Ziccheddu;
    • Carniti, Cristiana;
    • Montefusco, Vittorio;
    • Corradini, Paolo;
    • Anderson, Kenneth C.;
    • Moreau, Philippe;
    • Papaemmanuil, Elli;
    • Alexandrov, Ludmil;
    • Puente, Xose;
    • Campo, Elias
    Publication type:
    Article
    30
    31

    Prevalence of Ocular Disorders in Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e104, doi. 10.1016/j.clml.2017.03.189
    By:
    • Montefusco, Vittorio;
    • Pennisi, Martina;
    • Berchicci, Luigi;
    • Miserocchi, Elisabetta;
    • Cacioppo, Viviana;
    • David, Alessandro;
    • Scialdone, Antonio;
    • Lara, Crucitti;
    • Lo Russo, Ilaria;
    • Modorati, Giulio;
    • Corradini, Paolo
    Publication type:
    Article
    32
    33

    A Multicenter Phase I/II EMN Study of Carfilzomib in Combination with Bendamustine and Dexamethasone (CBd) in Relapsed and/or Refractory Patients with Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e125, doi. 10.1016/j.clml.2017.03.227
    By:
    • Gay, Francesca;
    • Günther, Andreas;
    • Offidani, Massimo;
    • Engelhardt, Monika;
    • Schub, Natalie;
    • Gentili, Silvia;
    • Montefusco, Vittorio;
    • Poenisch, Wolfram;
    • Patriarca, Francesca;
    • Angelucci, Emanuele;
    • Astolfi, Monica;
    • Corradini, Paolo;
    • Einsele, Hermann;
    • Sonneveld, Pieter;
    • Palumbo, Antonio;
    • Gramatzki, Martin
    Publication type:
    Article